Latest Insider Transactions at Cytokinetics Inc (CYTK)
This section provides a real-time view of insider transactions for Cytokinetics Inc (CYTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CYTOKINETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CYTOKINETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2022
|
Ching Jaw SVP Finance & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,022
+4.22%
|
-
|
|
Feb 16
2022
|
Fady Ibraham Malik EVP Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
7,148
+2.26%
|
-
|
|
Feb 16
2022
|
Mark A Schlossberg SVP - Legal & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
5,025
+4.39%
|
-
|
|
Feb 16
2022
|
Robert Wong VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,987
+3.57%
|
-
|
|
Feb 07
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.7%
|
$330,000
$33.86 P/Share
|
|
Feb 07
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.63%
|
$70,000
$7.96 P/Share
|
|
Jan 03
2022
|
Muna Bhanji Director |
BUY
Grant, award, or other acquisition
|
Direct |
244
+4.45%
|
$11,224
$46.0 P/Share
|
|
Jan 03
2022
|
Robert Califf Director |
BUY
Grant, award, or other acquisition
|
Direct |
122
+1.99%
|
$5,612
$46.0 P/Share
|
|
Jan 03
2022
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
244
+1.78%
|
$11,224
$46.0 P/Share
|
|
Jan 03
2022
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
244
+3.36%
|
$11,224
$46.0 P/Share
|
|
Jan 03
2022
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
122
+1.74%
|
$5,612
$46.0 P/Share
|
|
Jan 03
2022
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
122
+1.74%
|
$5,612
$46.0 P/Share
|
|
Jan 03
2022
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
122
+1.99%
|
$5,612
$46.0 P/Share
|
|
Dec 27
2021
|
Sandford D Smith Director |
SELL
Open market or private sale
|
Direct |
28,290
-50.24%
|
$1,273,050
$45.79 P/Share
|
|
Dec 27
2021
|
Sandford D Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
28,290
+32.61%
|
$565,800
$20.45 P/Share
|
|
Dec 27
2021
|
Wendall Wierenga Director |
SELL
Open market or private sale
|
Direct |
4,166
-38.11%
|
$183,304
$44.37 P/Share
|
|
Dec 27
2021
|
Wendall Wierenga Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+27.59%
|
$20,830
$5.46 P/Share
|
|
Dec 23
2021
|
Edward M. Md Kaye Director |
SELL
Open market or private sale
|
Direct |
15,000
-68.92%
|
$675,000
$45.0 P/Share
|
|
Dec 23
2021
|
Edward M. Md Kaye Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+40.8%
|
$105,000
$7.61 P/Share
|
|
Dec 09
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
29,166
-8.67%
|
$1,049,976
$36.49 P/Share
|
|
Dec 09
2021
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
29,166
+7.82%
|
$174,996
$6.3 P/Share
|
|
Nov 19
2021
|
Sandford D Smith Director |
SELL
Open market or private sale
|
Direct |
29,032
-51.52%
|
$1,190,312
$41.21 P/Share
|
|
Nov 19
2021
|
Sandford D Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,032
+33.26%
|
$348,384
$12.03 P/Share
|
|
Nov 12
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
4,143
-1.14%
|
$161,577
$39.63 P/Share
|
|
Nov 12
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,143
+1.12%
|
$24,858
$6.0 P/Share
|
|
Nov 11
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.33%
|
$78,000
$39.56 P/Share
|
|
Nov 09
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
45,000
-13.94%
|
$1,845,000
$41.76 P/Share
|
|
Nov 09
2021
|
David Cragg Chief HR & Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+12.23%
|
$405,000
$9.65 P/Share
|
|
Nov 08
2021
|
L Patrick Gage Director |
SELL
Open market or private sale
|
Direct |
26,468
-28.06%
|
$1,085,188
$41.33 P/Share
|
|
Nov 08
2021
|
L Patrick Gage Director |
BUY
Exercise of conversion of derivative security
|
Direct |
26,468
+20.75%
|
$105,872
$4.74 P/Share
|
|
Nov 05
2021
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
30,996
-51.49%
|
$1,239,840
$40.0 P/Share
|
|
Nov 05
2021
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,996
+33.24%
|
$309,960
$10.07 P/Share
|
|
Nov 05
2021
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
8,503
-39.08%
|
$340,120
$40.0 P/Share
|
|
Nov 05
2021
|
John T Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,503
+28.1%
|
$42,515
$5.88 P/Share
|
|
Nov 01
2021
|
David Cragg Chief HR & Admin Officer |
SELL
Open market or private sale
|
Direct |
25,000
-8.13%
|
$850,000
$34.89 P/Share
|
|
Nov 01
2021
|
David Cragg Chief HR & Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+7.42%
|
$150,000
$6.0 P/Share
|
|
Oct 29
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.37%
|
$175,000
$35.8 P/Share
|
|
Oct 29
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.35%
|
$30,000
$6.0 P/Share
|
|
Oct 19
2021
|
Ching Jaw SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
35,687
-40.21%
|
$1,249,045
$35.73 P/Share
|
|
Oct 19
2021
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
10,332
-45.53%
|
$361,620
$35.73 P/Share
|
|
Oct 19
2021
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,332
+30.34%
|
$61,992
$6.72 P/Share
|
|
Oct 19
2021
|
Mark A Schlossberg SVP - Legal & General Counsel |
SELL
Open market or private sale
|
Direct |
19,979
-28.21%
|
$699,265
$35.74 P/Share
|
|
Oct 19
2021
|
Mark A Schlossberg SVP - Legal & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
19,979
+22.0%
|
$139,853
$7.03 P/Share
|
|
Oct 14
2021
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.38%
|
$185,000
$37.74 P/Share
|
|
Oct 14
2021
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.36%
|
$30,000
$6.0 P/Share
|
|
Oct 14
2021
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.31%
|
$74,000
$37.73 P/Share
|
|
Oct 01
2021
|
Robert Califf Director |
BUY
Grant, award, or other acquisition
|
Direct |
153
+2.54%
|
$5,508
$36.74 P/Share
|
|
Oct 01
2021
|
L Patrick Gage Director |
BUY
Grant, award, or other acquisition
|
Direct |
510
+1.73%
|
$18,360
$36.74 P/Share
|
|
Oct 01
2021
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
306
+2.26%
|
$11,016
$36.74 P/Share
|
|
Oct 01
2021
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
306
+4.33%
|
$11,016
$36.74 P/Share
|